Irinotecan + Eltrombopag Interaction
Moderateinteraction on record
Description
BCRP substrate (SN-38 metabolite); eltrombopag may increase exposure. Monitor closely for excessive drug exposure.
Mechanism
BCRP transporter inhibition
Source: NLP:eltrombopag